Skip to main content
ATAI Life Sciences N.V. logo

ATAI Life Sciences N.V. — Investor Relations & Filings

Ticker · ATAI ISIN · NL0015000DX5 LEI · 391200Z8UWPJSNBNCA11 US Manufacturing
Filings indexed 319 across all filing types
Latest filing 2026-03-20 Regulatory Filings
Country NL Netherlands
Listing US ATAI

About ATAI Life Sciences N.V.

https://atai.life/

AtaiBeckley is a clinical-stage biopharmaceutical company focused on developing innovative treatments for mental health disorders. Following a strategic combination with Beckley Psytech, the company advances a pipeline of psychedelic-inspired therapies, including hallucinogens and entactogens. Its mission is to address significant unmet needs in mental health by creating effective, rapid-acting, and convenient evidence-based treatments. The company targets a range of psychiatric conditions, such as depression and schizophrenia, with the goal of transforming patient outcomes on a large scale.

Recent filings

Filing Released Lang Actions
144 - Atai Beckley N.V. (0001840904) (Subject)
Regulatory Filings
2026-03-20 English
15-12G
Regulatory Filings
2025-12-30 English
POSASR
Regulatory Filings
2025-12-30 English
S-8 POS
Regulatory Filings
2025-12-30 English
8-K
Regulatory Filings
2025-12-05 English
424B7
Prospectus
2025-12-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.